Suppr超能文献

腺瘤检出率的可靠性基于操作量。

Reliability of adenoma detection rate is based on procedural volume.

机构信息

Boston University Medical Center, Boston, MA, USA.

出版信息

Gastrointest Endosc. 2013 Mar;77(3):376-80. doi: 10.1016/j.gie.2012.10.023. Epub 2012 Dec 1.

Abstract

BACKGROUND

Adenoma detection rate (ADR) is a widely touted quality measure for colonoscopy. However, there are no guidelines for minimum numbers of procedures to include to ensure reliable ADR estimates.

OBJECTIVE

We sought to illustrate how a confidence interval (CI)-based approach can suggest minimum numbers for ADR calculations and provide a reasonable method for comparing ADRs and the mean number of adenomas per procedure (MAP) when relying on limited numbers of procedures.

DESIGN

Mathematical modeling and use of real world clinical inputs.

SETTING

Academic medical center.

PATIENTS

Adults presenting for screening colonoscopy. METHODS AND MAIN OUTCOME MEASUREMENTS: We calculated 95% CIs for theoretical ADRs of 15% to 40%, with varying sample sizes, using the formula p ± 1.96√[p(1 - p)/n], where p is the ADR point estimate and n is the number of procedures. We then compared the ADRs and 95% CIs among 17 endoscopists to determine whether CIs offered important additional information. We also calculated MAPs with 95% CIs using the formula x ± 1.96(sd/√n), where x is the MAP point estimate and sd is the standard deviation of the number of adenomas detected per procedure.

RESULTS

Large numbers of procedures (eg, 500) are needed to provide narrow CIs for typical ADR estimates. Although 10 of the 17 endoscopists had an ADR below the group's combined mean ADR of 34%, only 3 endoscopists had CIs failing to contain 34%. Likewise, whereas 9 endoscopists had MAPs below the group's combined mean MAP of 0.66, only 4 had CIs failing to contain 0.66.

LIMITATIONS

Clinical examples come from small numbers of physicians and patients.

CONCLUSIONS

Large sample sizes are required for a reliable assessment of an endoscopist's ADR. When calculating ADRs and MAPs, 95% CIs account for uncertainty and better reflect endoscopist performance.

摘要

背景

腺瘤检出率(ADR)是广泛推崇的结肠镜检查质量指标。然而,目前尚无纳入最低例数以确保可靠的 ADR 估算的指南。

目的

我们旨在展示基于置信区间(CI)的方法如何提示 ADR 计算的最低例数,并在依赖有限例数的情况下,为比较 ADR 和每例平均腺瘤数(MAP)提供合理的方法。

设计

数学建模和真实世界临床数据的应用。

设置

学术医疗中心。

患者

接受筛查性结肠镜检查的成年人。

方法和主要观察指标

我们使用公式 p ± 1.96√[p(1 - p)/n],计算了 15%至 40%理论 ADR 的 95%CI,其中 p 为 ADR 点估计值,n 为操作例数,以此来计算不同样本量的 95%CI。然后,我们比较了 17 名内镜医生的 ADR 和 95%CI,以确定 CI 是否提供了重要的附加信息。我们还使用公式 x ± 1.96(sd/√n),计算了 MAP 和 95%CI,其中 x 为 MAP 点估计值,sd 为每例检测到的腺瘤数的标准差。

结果

需要大量的操作例数(例如,500 例)才能为典型 ADR 估计提供狭窄的 CI。尽管 17 名内镜医生中有 10 人的 ADR 低于组内平均 ADR(34%),但只有 3 名内镜医生的 CI 未能包含 34%。同样,9 名内镜医生的 MAP 低于组内平均 MAP(0.66),但只有 4 名内镜医生的 CI 未能包含 0.66。

局限性

临床实例来自少数医生和患者。

结论

需要大量的样本量才能对内镜医生的 ADR 进行可靠评估。在计算 ADR 和 MAP 时,95%CI 考虑了不确定性,并更好地反映了内镜医生的表现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验